Cells, Vol. 11, Pages 1667: Features of ZED1227: The First-in-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease

Added 42 days ago (17.05.2022)
Authors: Christian Büchold; Martin Hils; Uwe Gerlach; Johannes Weber; Christiane Pelzer; Andreas Heil; Daniel Aeschlimann; Ralf Pasternack
Journal: Molecules
Read article